QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of Verogen, a leader in the use of next-generation sequencing (NGS) technologies to drive the future of human identification (HID) and forensic investigation.
Biocoat, Inc., a leading specialty manufacturer of hydrophilic biomaterial coatings, services and dip-coating equipment for medical devices, announced today that GTCR, a leading private equity firm, has made a strategic investment in the Company. The transaction closed on November 1, 2022.
Verogen, Inc. and Gene by Gene today announced a partnership to accelerate the adoption of forensic investigative genetic genealogy. As part of the agreement, Gene by Gene, parent company of FamilyTreeDNA, will support DNA uploads generated from the Verogen ForenSeq Kintelligence kit, the only ANAB accredited technology approved for forensic investigative genetic genealogy (FIGG). This …
Onkos Surgical, a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic procedures, today announced that it has received 510(k) clearance for its My3D® Personalized Pelvic Reconstruction system.
Greenbrook TMS Inc. (TSX: GTMS, NASDAQ: GBNH) (“Greenbrook” or the “Company”), a leading provider of Transcranial Magnetic Stimulation (“TMS”) therapy in the United States, is pleased to announce the closing of its previously-announced acquisition (the “Acquisition”) of Check Five LLC, a Delaware limited liability company (doing business as “Success TMS”) (“Success TMS”). In addition, Greenbrook …
NutriSense, the metabolic health technology platform that couples real-time data with credentialed nutrition professionals for personalized support, announced the initial closing of a $25 million Series A round. This financing, led by 1315 Capital, a healthcare growth equity firm, will be used to drive continued growth as the company serves more consumers seeking to optimize …
Homestead Smart Health Plans is pleased to announce the appointment of John Powers as President of Homestead. Powers, a senior healthcare execut29ive with over 25 years experience in disrupting the status quo and leading change in the cost management space, brings extensive knowledge of the marketplace to Homestead’s executive team. He has a proven track …
Onkos Surgical, Inc., a rapidly growing, leading innovator of solutions for musculoskeletal oncology and complex orthopaedic conditions, announced today that it has entered into a definitive agreement with Stryker to acquire the Juvenile Tumour System (JTS). The system enables limb stabilization and growth in pediatric patients affected by bone cancers, severe arthropathy, severe trauma, revisions, …
Reaction Biology (“Reaction” or the “Company”), an industry- leading provider of drug discovery services, today announced the closing of a significant investment from Cobepa, an international private equity firm, to fuel the Company’s continued growth and service line expansion.
Aktana, the leader in intelligent customer engagement for the global life sciences industry, announced a new partnership with Cantab Pi, a data science company based in Cambridge, UK. Founded to address the unique data needs of European markets, Cantab Pi brings dynamic targeting capabilities and more than two million healthcare professional (HCP) profiles from a range …
JDS Therapeutics, LLC (“JDS”) announced today that it sold its specialty ingredient subsidiary, Nutrition21, LLC (“Nutrition21”), to Everwell Health Holdings, LLC (“Everwell Health” or “Everwell”), a newly-formed platform company of RoundTable Healthcare Partners (“RoundTable”). The terms of the transaction were not disclosed.